Alira Health as Strategic Advisor to Benvic in Acquisition Luc & Bel

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services.

News
Category:
Published on:
November 29, 2020

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.

Benvic is a French group leader in the production of highly innovative PVC-based thermoplastic solutions and ecological biopolymers.

For more information, please contact Gabriele Brambilla.

To read the full press release

Click here

Aenean ut neque vehicula, iaculis odio ut, porta risus. In gravida libero faucibus ex vulputate pharetra. Donec sed sapien odio. Donec vel pellentesque eros. Aliquam erat volutpat. Suspendisse luctus massa accumsan, egestas lacus ac, aliquam libero. Praesent mollis magna vel mi fermentum pulvinar. Fusce quis ultricies sapien, eu suscipit ligula. Duis ut enim ac felis scelerisque sodales. Quisque a elit ac mi cursus posuere vitae sed augue. Nunc varius a ex eget posuere. Nullam fringilla aliquet diam. Maecenas mattis ac massa id fermentum. Proin convallis dui sit amet urna volutpat, ac rutrum magna volutpat. Sed gravida tincidunt laoreet. Nulla nec enim vitae nulla vehicula tempus.

Related news

Multimedia March 24, 2023
Webinar Replay: MedTech CDMO: Market and M&A Trends in the U.S. in 2023
Watch this webinar hosted by MassMEDIC to discover the current trends shaping the US medical device outsourcing landscape, with a particular focus on its performance and business outlook,(...)
CDMO MedTech
Events January 11, 2023
MD&M West 2023
Join our colleague Carlo Stimamiglio for his presentation “MedTech CDMO: Market and M&A Trends in 2023”, as he goes over key takeaways from our upcoming 2023 US MedTech CDMO Report.
CDMO MedTech
Blog December 6, 2022
2021-22 Review and 2023 Outlook: Report on European MedTech CDMO Industry
A return to normalcy has accelerated growth for Europe’s MedTech CDMO industry, but individual companies may be at risk given the increased competitive pressure, logistics disruption,(...)
CDMO MedTech
Blog November 10, 2022
How to Choose the Right Analytical Methods
In this article, we focus on the analytical method development around your biologics. Analytical method development is an important component of biologics development and the control(...)
Biotech CDMO Drug Development
Events October 6, 2022
The MedTech Conference 2022
We are pleased to share that we will be joining the MedTech Conference 2022 as sponsors and speakers! This year’s edition will have more than 100 sessions focusing on today’s hot topics.
M&A MedTech Regulatory
Blog September 14, 2022
Critical Quality Attributes for Drug Products
In this article, we will explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Biotech CDMO Drug Development
Blog September 8, 2022
Best Practices in the CDMO Selection Process
The CDMO series provides sound advice to agile biotech companies in identifying and selecting the right Contract Development and Manufacturing Organization (CDMO) for advancing the(...)
CDMO
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.